Safety of Withdrawal of Pharmacological Treatment for Recovered HER2 Targeted Therapy Related Cardiac Dysfunction

NCT05880160 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Cardiotoxicity
HER2-positive Breast Cancer
Heart Failure
Cancer, Therapy-Related

Interventions

OTHER: Phased withdrawal of heart failure medications

Sponsor

University College, London

Collaborators

[object Object]
[object Object]
[object Object]